Phosphodiesterase Type 5 Inhibitor and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Overall Market Size
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size: 2021 VS 2028
2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players in Global Market
3.2 Top Global Phosphodiesterase Type 5 (PDE5) Inhibitor Companies Ranked by Revenue
3.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Phosphodiesterase Type 5 (PDE5) Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phosphodiesterase Type 5 (PDE5) Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 Phosphodiesterase Type 5 (PDE5) Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 Phosphodiesterase Type 5 (PDE5) Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Markets, 2021 & 2028
4.1.2 Sildenafil
4.1.3 Tadalafil
4.1.4 Avanafil
4.1.5 Vardenafil
4.2 By Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue & Forecasts
4.2.1 By Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2022
4.2.2 By Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2023-2028
4.2.3 By Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacies
5.1.5 Other
5.2 By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue & Forecasts
5.2.1 By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2022
5.2.2 By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2023-2028
5.2.3 By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue & Forecasts
6.2.1 By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2022
6.2.2 By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2023-2028
6.2.3 By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028
6.3.2 US Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.3.3 Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.3.4 Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028
6.4.2 Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.3 France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.4 U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.5 Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.6 Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.7 Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.4.8 Benelux Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028
6.5.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.5.3 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.5.4 South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.5.5 Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.5.6 India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028
6.6.2 Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.6.3 Argentina Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028
6.7.2 Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.7.3 Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.7.4 Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
6.7.5 UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.1.4 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.2.4 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.3.4 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.4.4 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.4.5 Novartis AG Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.5.4 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Corporate Summary
7.6.2 GlaxoSmithKline plc Business Overview
7.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.6.4 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline plc Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.7.4 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.8.4 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.8.5 AstraZeneca Key News
7.9 BaiYunShan General Factory
7.9.1 BaiYunShan General Factory Corporate Summary
7.9.2 BaiYunShan General Factory Business Overview
7.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.9.4 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.9.5 BaiYunShan General Factory Key News
7.10 SK Chemicals
7.10.1 SK Chemicals Corporate Summary
7.10.2 SK Chemicals Business Overview
7.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.10.4 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.10.5 SK Chemicals Key News
7.11 Teva Pharma
7.11.1 Teva Pharma Corporate Summary
7.11.2 Teva Pharma Business Overview
7.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.11.4 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.11.5 Teva Pharma Key News
7.12 Dong-A ST
7.12.1 Dong-A ST Corporate Summary
7.12.2 Dong-A ST Business Overview
7.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.12.4 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.12.5 Dong-A ST Key News
7.13 Metuchen Pharma
7.13.1 Metuchen Pharma Corporate Summary
7.13.2 Metuchen Pharma Business Overview
7.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.13.4 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.13.5 Metuchen Pharma Key News
7.14 Seoul Pharma
7.14.1 Seoul Pharma Corporate Summary
7.14.2 Seoul Pharma Business Overview
7.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.14.4 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.14.5 Seoul Pharma Key News
7.15 Vectura Group
7.15.1 Vectura Group Corporate Summary
7.15.2 Vectura Group Business Overview
7.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Major Product Offerings
7.15.4 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global Market (2017-2022)
7.15.5 Vectura Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Opportunities & Trends in Global Market
Table 2. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers in Global Market
Table 3. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints in Global Market
Table 4. Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor in Global Market
Table 5. Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type
Table 9. List of Global Tier 1 Phosphodiesterase Type 5 (PDE5) Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phosphodiesterase Type 5 (PDE5) Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 32. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 35. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 38. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 41. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 44. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline plc Corporate Summary
Table 46. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 47. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 50. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 53. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 54. BaiYunShan General Factory Corporate Summary
Table 55. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 56. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 57. SK Chemicals Corporate Summary
Table 58. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 59. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 60. Teva Pharma Corporate Summary
Table 61. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 62. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 63. Dong-A ST Corporate Summary
Table 64. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 65. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 66. Metuchen Pharma Corporate Summary
Table 67. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 68. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 69. Seoul Pharma Corporate Summary
Table 70. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 71. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 72. Vectura Group Corporate Summary
Table 73. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offerings
Table 74. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Type in 2021
Figure 2. Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Application in 2021
Figure 3. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2021
Figure 8. By Type - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
